methylprednisolone hemisuccinate has been researched along with Acute Lymphoid Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dacosta, Y; Manny, N; Nagler, A; Or, R; Toren, A; Varadi, G | 1 |
| Hiçsönmez, G; Olcay, L; Tunç, B; Tuncer, MA | 1 |
| McElwain, TJ; Meller, ST; Pinkerton, CR; Ryalls, MR; Talbot, D | 1 |
3 other study(ies) available for methylprednisolone hemisuccinate and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation.
Topics: ABO Blood-Group System; Anemia, Hemolytic; B-Lymphocytes; Blood Group Incompatibility; Child; Combined Modality Therapy; Erythrocytes; Exchange Transfusion, Whole Blood; Female; Glucocorticoids; Hematopoietic Stem Cell Transplantation; Humans; Male; Methylprednisolone Hemisuccinate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1996 |
Effect of short-course, high-dose steroid therapy in a child with myelodysplastic syndrome.
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow; Child, Preschool; Female; Humans; Methylprednisolone Hemisuccinate; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Steroids; Treatment Outcome | 2001 |
High-dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukaemia.
Topics: Administration, Oral; Adolescent; Bone Marrow; Brain Neoplasms; Child; Child, Preschool; Female; Humans; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 1992 |